Articles tagged "Kidney/liver transplantation"

2022 American Transplant Congress
Outcomes of Sensitized Simultaneous Liver-Kidney Transplant
E. R. Kitchel, T. Tan, A. Wadhwa, D. G. Farmer, S. Bunnapradist
David Geffen School of Medicine, Los Angeles, CA
*Purpose: Pre-formed donor-specific HLA antibodies (DSAs) in simultaneous liver-kidney transplants (SLKTs) have been associated with increased risk of antibody mediated rejection (AMR) and negative transplant…
2022 American Transplant Congress
Simultaneous Liver and Kidney Transplantation and Gender Disparities in Transplant Access and Outcomes
G. Peschard¹, M. Wang², Y. Al-Hosni³, K. Lentine⁴, S. Chang², T. Alhamad⁵
¹Nephrology, UCSF, San Francisco, CA, ²Division of Public Health Sciences, Department of Surgery, Washington University in St Louis, Saint Louis, MO, ³Division of General Medical Sciences, Washington University in St Louis, Saint Louis, MO, ⁴Saint Louis University Center for Abdominal Transplantation,, Saint Louis University, Saint Louis, MO, ⁵Nephrology, Washington University in St Louis, St Louis, MO
*Purpose: The frequency of simultaneous liver-kidney transplantation (SLKT) has been rising since the implementation of the Model for End-stage Liver Disease (MELD)-liver allocation system in…
2022 American Transplant Congress
Kidney Allograft Loss After Simultaneous Liver Kidney (SLK) Transplant Before and After the New SLK Allocation Criteria Implementation
A. P. Bregman¹, S. Jackson², N. Lim¹, J. Lake¹, S. Riad¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Analytics, Mhealth-Fairview, Minneapolis, MN
*Purpose: On August 10, 2017 UNOS/OPTN implemented new allocation criteria for simultaneous liver-kidney (SLK) transplants. We sought to examine the association between the new allocation…
2022 American Transplant Congress
Infections Following Rejection Therapies in Solid Organ Transplant Recipients
S. Gupta¹, J. Gea-Banacloche², H. Me³, D. M. Chascsa⁴, H. R. Vikram², R. Yaman¹, L. Kodali³
¹Internal Medicine, Mayo Clinic, Scottsdale, AZ, ²Infectious Diseases, Mayo Clinic, Phoenix, AZ, ³Transplant Nephrology, Mayo Clinic, Phoenix, AZ, ⁴Hepatology, Mayo Clinic, Phoenix, AZ
*Purpose: Infections are known complications of solid-organ transplant. They are most prevalent in the first 12 months after transplant when immunosuppression is at its peak.…
2022 American Transplant Congress
Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation
E. Takoushian¹, E. Brandon¹, B. Samstein², K. Halazun²
¹Liver Transplantation, New York Presbyterian Weill Cornell, New York, NY, ²Weill Cornell Medical Center, New York, NY
*Purpose: LT is a novel therapy for patients with unresectable CRLM. 5 year survival using LT appears to be significantly better than systemic chemotherapy in…
2022 American Transplant Congress
Dynapenia Among Kidney Transplant Candidates and Recipients in the United States
A. S. Nalatwad¹, X. Chen¹, N. M. Chu¹, S. P. Norman², D. L. Segev¹, M. McAdams-Demarco¹
¹Epidemiology Research Group in Organ Transplantation, Johns Hopkins University School of Medicine, Baltimore, MD, ²Univ of Michigan Medical Ctr, Ann Arbor, MI
*Purpose: Among Kidney Transplant (KT) patients, sarcopenia, loss of muscle mass, is prevalent and has been associated with post-KT mortality. The burden of dynapenia, an…
2022 American Transplant Congress
Long-Term Implication of Kidney Injury Prior to Liver Transplantation for Acute Liver Failure
M. R. Cloonan¹, D. J. Cloonan², S. Westphal³, L. A. Dageforde¹, S. Merani¹
¹Division of Transplant, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, ²Division of Transplant Surgery, Massachusetts General Hospital, Boston, MA, ³University of Nebraska Medical Center, Omaha, NE
*Purpose: Acute liver failure (ALF) is a heterogeneous disease process that often includes acute kidney injury. Long-term sequelae of kidney impairment in patients with ALF…
2022 American Transplant Congress
Seroprevalence of HHV8 Among Donors and Recipients with HIV
P. H. Nambiar¹, T. Liang², J. D. Motter³, W. Werbel³, S. Mehta⁴, V. Kirchner⁵, M. Rana⁶, S. Florman⁷, J. Odim⁸, W. Miley⁹, N. Labo⁹, D. Whitby⁹, A. Massie¹⁰, D. Segev³, A. Tobian³, C. Durand²
¹Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, ²Medicine, Johns Hopkins University, Baltimore, MD, ³Johns Hopkins University, Baltimore, MD, ⁴New York University Langone Transplant Institute, New York, NY, ⁵University of Minnesota, Minneapolis, MN, ⁶Icahn School of Medicine at Mount Sinai, New York, NY, ⁷Mount Sinai Medical Center, New York, NY, ⁸National Institute of Health, Bethesda, MD, ⁹National Cancer Institute, Frederick, MD, ¹⁰Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Kaposi sarcoma (KS) can develop post-transplant via recipient HHV8 reactivation or donor-acquired HHV8. In the general US population, HHV8 seroprevalence is low (1-5%), yet…
2022 American Transplant Congress
Knowledge, Attitude, and Practices Regarding Covid-19 Among Solid Organ Transplant Patients at a Transplant Center in the United States: A Cross-Sectional Study
L. Wang, H. Oduor, M. Abualfoul, P. Acharya, M. Pagadala
Methodist Dallas Medical Center, Dallas, TX
*Purpose: To evaluate the knowledge, attitude, and practices (KAP) of patients who have undergone kidney and/or liver solid organ transplants (SOTs) during the COVID-19 pandemic.*Methods:…
2022 American Transplant Congress
Healthcare Cost And Kidney Allocation In Liver Recipients With Kidney Disease
Y. Lu¹, X. Cheng², S. Sanoff³, L. McElroy³
¹University of Michigan, Ann Arbor, MI, ²Stanford University, Palo Alto, CA, ³Duke University, Durham, NC
*Purpose: End stage kidney disease (ESKD) in liver transplant (LT) candidates is associated with worse survival. We sought to identify the predictors of ESKD in…

1
2
3
…
24
Next Page »